PMC:7534795 / 911-1276
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T52458 | 184-195 | Body_part | denotes | fatty acids | http://purl.org/sig/ont/fma/fma82738 |
| T68120 | 218-239 | Body_part | denotes | cardiovascular system | http://purl.org/sig/ont/fma/fma7161 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T3 | 218-239 | Body_part | denotes | cardiovascular system | http://purl.obolibrary.org/obo/UBERON_0004535 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T11 | 78-86 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T12 | 345-357 | Disease | denotes | coagulopathy | http://purl.obolibrary.org/obo/MONDO_0001531 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T45959 | 121-124 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T96471 | 218-239 | http://purl.obolibrary.org/obo/UBERON_0004535 | denotes | cardiovascular system |
| T55834 | 218-239 | http://www.ebi.ac.uk/efo/EFO_0000791 | denotes | cardiovascular system |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T5 | 168-195 | Chemical | denotes | polyunsaturated fatty acids | http://purl.obolibrary.org/obo/CHEBI_26208 |
| T6 | 184-195 | Chemical | denotes | fatty acids | http://purl.obolibrary.org/obo/CHEBI_35366 |
| T7 | 190-195 | Chemical | denotes | acids | http://purl.obolibrary.org/obo/CHEBI_37527 |
| T8 | 201-205 | Chemical | denotes | PUFA | http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T8 | 97-358 | Sentence | denotes | Accumulating literature has demonstrated the beneficial effects of n-3 polyunsaturated fatty acids (n-3 PUFA) toward the cardiovascular system, which include ameliorating uncontrolled inflammatory reactions, reduced oxidative stress and mitigating coagulopathy. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T3 | 313-329 | Phenotype | denotes | oxidative stress | http://purl.obolibrary.org/obo/HP_0025464 |
| T4 | 345-357 | Phenotype | denotes | coagulopathy | http://purl.obolibrary.org/obo/HP_0003256 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 35 | 201-205 | Gene | denotes | PUFA | Gene:9933 |
| 40 | 87-95 | Species | denotes | patients | Tax:9606 |
| 42 | 164-195 | Chemical | denotes | n-3 polyunsaturated fatty acids | MESH:D015525 |
| 59 | 78-86 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 60 | 345-357 | Disease | denotes | coagulopathy | MESH:D001778 |